Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.

NCT07684898

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
  • Fuyang Hospital, Affiliated to Anhui Medical University Fuyang, China
  • Fujian Medical University Union Hospital Fuzhou, China
  • Nanfang Hospital of Southern Medical University Guangzhou, China
View all 19 locations
View Trial Details
Recruiting

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

NCT06481306

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego - La Jolla La Jolla, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 33 locations
View Trial Details
Recruiting

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

NCT06083922

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tufts Medical Center (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT05160584

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • LKH Leoben Leoben, Austria
  • Krankenhaus der barmherzigen Schwestern Vienna, Austria
  • UZ Antwerpen Edegem, Belgium
  • Ziekenhuis Oost-Limburg Genk, Belgium
View all 90 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

NCT07221500

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Institute Denver, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 32 locations
View Trial Details
Recruiting

Hairy Cell Leukemia Patient Data Registry

NCT02560883

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations
  • University of Miami/Soffer Clinical Research Center Miami, Florida, United States
  • Mount Sinai Medical Center of Florida Miami Beach, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Rochester /Wilmot Cancer Institute Rochester, New York, United States
View Trial Details

Related conditions